Estimating COVID-19 vaccine effectiveness using data from the OpenSAFELY whole-population secure data environment
The COVID-19 pandemic led to unprecedented progress in linking National Health Service electronic health record data in England, and making these data available in secure, privacy-protecting environments. A collaborative group from the Universities of Bristol and Oxford, the London School of Hygiene and Tropical Medicine and the Harvard School of Public Health conducted a series of studies of COVID-19 vaccination, based on explicit emulation of target trials. I will present the OpenSAFELY secure data environment and describe our work on COVID-19 vaccine effectiveness conducted using OpenSAFELY.
Jonathan Sterne is Director of the NIHR Bristol Biomedical Research Centre, co-Director of Health Data Research UK South-West, and Professor of Medical Statistics and Epidemiology at the University of Bristol, UK. During the pandemic, he was co-lead of the UK’s Longitudinal Health and Wellbeing COVID-19 National Core Study, which linked population-scale electronic health records with highly characterised longitudinal population studies. This UK-wide collaboration produced research on COVID-19 vaccination and long COVID based on analyses of data on up to 55 million people, held within newly-created Secure Data Environments. Jonathan is Principal Investigator of the ART Cohort Collaboration of HIV cohort studies, which works closely with the HIV-CAUSAL collaboration based at the Harvard School of Public Health.
This seminar will be delivered in person and streamed online via Zoom. It will be recorded. To request access to the recording, please email .
No registration is required.
Date and time:
17 December, 4-5pm AEDT
Location:
Bio21 Institute Auditorium,
30 Flemington Road, Parkville
Zoom:
https://monash.zoom.us/j/82266367045?pwd=bwjjTnvaSm56EIYZlA9BSzp4u0kvyk.1
We gratefully acknowledge the support of the Bio21 Institute at the University of Melbourne in hosting this seminar.
